Lv1
12 积分 2024-06-17 加入
Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer
2天前
已完结
Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer
2天前
已完结
Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer
2天前
已完结
Abstract PS1-11-16: Clinical and Molecular Landscape of ESR1 and PIK3CA Co-Mutated Hormone Receptor-Positive Metastatic Breast Cancer (HR+ MBC): Insights from 8,626 Patients Including Polyclonality and TP53 Alterations
4天前
求助中
Molecular Classification of Breast Cancer
15天前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
17天前
已完结
Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity
22天前
已完结
Intratumoural vaccination via checkpoint degradation-coupled antigen presentation
22天前
已完结
Theoretical Investigation of 5-Fluorouracil and Tamoxifen Complex – Structural, Spectrum, DFT, ADMET and Docking Simulation
1个月前
已完结
Reprogramming innate immunity to overcome endocrine resistance in estrogen receptor‐positive breast cancer
1个月前
已完结
皖公网安备34019202002308
